Mixed connective tissue disease (MCTD) manifests as a number of cardiovascular diseases; however, myocardial infarction secondary to coronary artery disease has not been well documented. We present a case of a teenager with MCTD and known cardiac risk factors who developed an acute coronary syndrome.
Harris ED Jr.Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J M ed1990; 322: 1277-1289.
6.
Karrar A, Sequeira W, Block JA.Coronary artery disease in systemic lupus erythematosus: a review of the literature. Semin Athritis Rheum2001; 30: 436-443.
7.
Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR.Mixed connective tissue disease. An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J M ed1972; 52148-159.
8.
Langley RL, Treadwell EL.Cardiac tamponade and pericardial disorders in connective tissue diseases: case report and literature review. J Natl Med Assoc1994; 86: 149-153.
9.
Lash AD, Wittman AL, Quismorio FP Jr.Myocarditis in mixed connective tissue disease; clinical and pathologic study of three cases and review of the literature. Semin Arthritis Rheum1986; 15: 288-296.
10.
Hammann C, Genton CY, Delabays Aet al.Myocarditis of mixed connective tissue disease: favorable outcome after intravenous pulsed cyclophosphamide. Clin Rheumatol1999; 18: 85-87.
11.
Oetgen WJ, Mutter ML, Lawless OJ, Davia JE.Cardiac abnormalities in mixed connective tissue disease. Chest1983; 83: 185-188.
12.
Rebollar-Gonzalez V, Torre-Delgadillo A, Orea-Tejada Aet al.Cardiac conduction disturbances in mixed connective tissue disease. Rev Invest Clin2001; 53: 330-334.
13.
Alpert MA, Goldberg SH, Singsen BHet al.Cardiovascular manifestations of mixed connective tissue disease in adults. Circulation1983; 68: 1182-1193.
14.
Singsen BH, Bernstein BH, Kornreich HKet al.Mixed connective tissue disease in childhood. A clinical and serologic survey. J Pediatr1977; 90: 893-900.
15.
Nimelstein SH, Brody S, McShane D, Holman HR.Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine1980; 59: 239-248.
16.
Schiffrin EL.Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens2001; 14: 83S-89S.
17.
Filep JG, Bodolay E, Sipka Set al.Plasma endothelin correlates with antiendothelial antibodies with mixed connective tissue disease. Circulation1995; 92: 2969-2974.
18.
Bodolay E, Bojan F, Szegedi G, Stenszky V, Farid NR.Cytotoxic endothelial cell antibodies in mixed connective tissue disease. Immunol Lett1989; 20: 163-167.
19.
Slovut D, Olin JW.Fibromuscular dysplasia. N Engl J M ed2004; 350: 1862-1871.
20.
Son JW, Koh KK, Dang Q, Choi IS, Shin EK.Recurrent restenosis following stent and rotational atherectomy of coronary artery stenosis in Takayasu’s arteritis. Int J Cardiol1998; 65: 295-300.
21.
Ishii M, Ueno T, Ikeda Het al.Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease. Circulation2002; 105: 3004-3010.
22.
Lincoff AM, Kereiakes DJ, Mascelli MAet al.Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization. Circulation2001; 104; 163-167.
23.
Yutani C, Imakita M, Ishibashi-Ueda H, Tsukamoto Y, Nishida N, Ikeda Y.Coronary atherosclerosis and interventions: pathological sequences and restenosis. Pathol Int1999; 49: 273-290.
24.
Van der Wal AC, Becker AE, van der Loos CMet al.Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation1994; 89: 36-44.
